HOME >> BIOLOGY >> NEWS
Dr. Thomas Starzl receiving prestigious King Faisal International prize this week in Saudi Arabia

Transplant pioneer Thomas E. Starzl, M.D., Ph.D., professor of surgery at the University of Pittsburgh School of Medicine, will accept one of the world's most prestigious awards, the King Faisal International Prize for Medicine, at a formal ceremony to be held Feb. 17 in Riyadh, Saudi Arabia, under the auspices of the King of Saudi Arabia.

According to the King Faisal Foundation, the largest philanthropic organization in the Middle East, the prize is in recognition of Dr. Starzl's outstanding contributions in the field of organ transplantation. He shares the award with two other transplant pioneers, Norman E. Shumway, M.D., a heart transplant surgeon from Stanford University, and Sir Roy Calne, a liver transplant surgeon from the University of Cambridge, United Kingdom. Each will receive a uniquely cast, commemorative 24-carat, 200-gram gold medal. The award's cash endowment of $200,000 will be divided among the three winners.

"Professor Starzl's pioneering work has influenced all aspects of organ transplantation," said officials from the Faisal Foundation when the winners of the prizes were announced in December.

Dr. Starzl performed the world's first liver transplant in 1963 at the University of Colorado. In 1962 and 1963, he introduced the concept of incorporating corticosteroids into the immunosuppression regimen for patients receiving kidney transplants from non-identical human living donors, which led to the largest series of kidney transplants and invigorated clinical attempts throughout the world. Lessons learned from kidney transplantation and other discoveries he made about liver physiology resulted in his performing the world's first successful liver transplant in 1967.

Since coming to the University of Pittsburgh in 1981, Dr. Starzl pioneered the immunosuppressive agent tacrolimus, resulting in significant improvements in organ transplant survival rates and allowing successful transplantation of the small intestine and multivisceral graf
'"/>

Contact: Lisa Rossi
rossil@msx.upmc.edu
412-647-3555
University of Pittsburgh Medical Center
11-Feb-2001


Page: 1 2 3

Related biology news :

1. UCRs Thomas Miller awarded prestigious medal from Academy of Sciences of the Czech Republic
2. Gene expression ratio identifies risk of recurrence in breast cancer patients receiving tamoxifen
3. DuPont part of science-based consortium receiving U.S. Dept. of Energy Bio-Refinery grant
4. Research shows different races, ethic groups receiving different levels of preventive care
5. Jefferson researchers find access to new methods of HIV prevention for pregnant women and newborns may depend on where they were receiving care
6. Gladstone investigator Mike McCune wins prestigious NIH Directors Pioneer Award
7. Carnegie Mellon computational biologist Russell Schwartz receives prestigious CAREER award
8. Brown earns prestigious geography award
9. Ohio State wetlands professor wins prestigious Water Prize
10. Top US scientist honored with prestigious award
11. Dr. Walter Reich, Ph.D., receives prestigious AAAS 2003 Scientific Freedom and Responsibility Award

Post Your Comments:
(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying ... power and potential for genomic science as a means ... disease prevention and treatment.  I was honored to participate ... government-funded precision medicine program. Since the ... science of genomics—from the first sequenced genome of a ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the ... report to their offering. , The ... individual is who she/he is claiming to be, and for ... unique physical characteristics, such as fingerprint, hand or palm print, ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
(Date:3/3/2015)... Experts and industry insiders from around the ... Alltech REBELation exploring innovation, inspiration and world-changing ideas in ... 31st year, Alltech’s annual international conference traditionally draws more ... to join the REBELation at an extra discount registration ... at which point the standard early registration rate will ...
(Date:3/3/2015)... 2015 /CNW/- SQI Diagnostics Inc. (TSX:V: SQD), a life sciences ... products for advanced microarray diagnostics, today announced it ... its Management team. In his capacity as CFO ... from a development stage to a commercially successful ... Company,s capital market strategy and to secure funding ...
(Date:3/3/2015)... 3, 2015  Regenicin, Inc. (OTC Bulletin Board: ... development of and commercialization of regenerative cell therapies to ... today that it has received the final payment to ... Inc. (OTC Bulletin Board: AMBS ). ... the final payments due to Regenicin in the amount ...
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  RegeneRx ... an editorial in the scientific journal, Expert Opinion ... and his colleague, Dr. Zhenggang Zhang , at ... reported that Thymosin beta 4 (TB4) has ... (PNS) remodeling 24 hours or more post-injury, leading to ...
Breaking Biology Technology:World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
Cached News: